A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic ; volume:271 ; number:9 ; day:27 ; month:6 ; year:2024 ; pages:5813-5824 ; date:9.2024
Journal of neurology ; 271, Heft 9 (27.6.2024), 5813-5824, 9.2024
- Creator
-
Lal, Anoushka P.
Foong, Yi Chao
Sanfilippo, Paul G.
Spelman, Tim
Rath, Louise
Levitz, David
Fabis-Pedrini, Marzena
Foschi, Matteo
Habek, Mario
Kalincik, Tomas
Roos, Izanne
Lechner-Scott, Jeannette
John, Nevin
Soysal, Aysun
D’Amico, Emanuele
Gouider, Riadh
Mrabet, Saloua
Gross-Paju, Katrin
Cárdenas-Robledo, Simón
Moghadasi, Abdorreza Naser
Sa, Maria Jose
Gray, Orla
Oh, Jiwon
Reddel, Stephen
Ramanathan, Sudarshini
Al-Harbi, Talal
Altintas, Ayse
Hardy, Todd A.
Ozakbas, Serkan
Alroughani, Raed
Kermode, Allan G.
Surcinelli, Andrea
Laureys, Guy
Eichau, Sara
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Hodgkinson, Suzanne
Ramo-Tello, Cristina
Maimone, Davide
McCombe, Pamela
Spitaleri, Daniele
Sanchez-Menoyo, Jose Luis
Yetkin, Mehmet Fatih
Baghbanian, Seyed Mohammad
Karabudak, Rana
Al-Asmi, Abdullah
Jakob, Gregor Brecl
Khoury, Samia J.
Etemadifar, Masoud
Pesch, Vincent van
Buzzard, Katherine
Taylor, Bruce
Butzkueven, Helmut
Walt, Anneke Van der
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-024-12518-7
- URN
-
urn:nbn:de:101:1-2411212132501.096871543863
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-15T07:32:40+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lal, Anoushka P.
- Foong, Yi Chao
- Sanfilippo, Paul G.
- Spelman, Tim
- Rath, Louise
- Levitz, David
- Fabis-Pedrini, Marzena
- Foschi, Matteo
- Habek, Mario
- Kalincik, Tomas
- Roos, Izanne
- Lechner-Scott, Jeannette
- John, Nevin
- Soysal, Aysun
- D’Amico, Emanuele
- Gouider, Riadh
- Mrabet, Saloua
- Gross-Paju, Katrin
- Cárdenas-Robledo, Simón
- Moghadasi, Abdorreza Naser
- Sa, Maria Jose
- Gray, Orla
- Oh, Jiwon
- Reddel, Stephen
- Ramanathan, Sudarshini
- Al-Harbi, Talal
- Altintas, Ayse
- Hardy, Todd A.
- Ozakbas, Serkan
- Alroughani, Raed
- Kermode, Allan G.
- Surcinelli, Andrea
- Laureys, Guy
- Eichau, Sara
- Prat, Alexandre
- Girard, Marc
- Duquette, Pierre
- Hodgkinson, Suzanne
- Ramo-Tello, Cristina
- Maimone, Davide
- McCombe, Pamela
- Spitaleri, Daniele
- Sanchez-Menoyo, Jose Luis
- Yetkin, Mehmet Fatih
- Baghbanian, Seyed Mohammad
- Karabudak, Rana
- Al-Asmi, Abdullah
- Jakob, Gregor Brecl
- Khoury, Samia J.
- Etemadifar, Masoud
- Pesch, Vincent van
- Buzzard, Katherine
- Taylor, Bruce
- Butzkueven, Helmut
- Walt, Anneke Van der
- SpringerLink (Online service)
Other Objects (12)
Current Disease-Modifying Therapies in Multiple Sclerosis
Disease-modifying treatments in Alzheimer’s disease
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Lithium as a disease-modifying agent for prion diseases
Current experimental disease-modifying therapeutics for multiple system atrophy
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
Disease-modifying factors in hereditary angioedema: an RNA expression-based screening
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Current Disease-Modifying Therapies in Multiple Sclerosis
Disease-modifying treatments in Alzheimer’s disease
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Lithium as a disease-modifying agent for prion diseases
Current experimental disease-modifying therapeutics for multiple system atrophy
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
Disease-modifying factors in hereditary angioedema: an RNA expression-based screening
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Current Disease-Modifying Therapies in Multiple Sclerosis
Disease-modifying treatments in Alzheimer’s disease
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Lithium as a disease-modifying agent for prion diseases
Current experimental disease-modifying therapeutics for multiple system atrophy
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
Disease-modifying factors in hereditary angioedema: an RNA expression-based screening